[HTML][HTML] Optimization of paclitaxel loaded poly (ε-caprolactone) nanoparticles using Box Behnken design

N Sathyamoorthy, D Magharla, P Chintamaneni… - Beni-Suef University …, 2017 - Elsevier
Optimization is a critical process in the development of nanoparticles to apprehend the
formulation variables and quality attributes. The purpose of this study was to evaluate the …

[PDF][PDF] Screening of factors using Plackett Burman design in the preparation of capecitabine-loaded nano polymeric micelles

AB Kuchekar, AP Pawar - Int J Pharm Pharm Sci, 2014 - researchgate.net
Objective: Quality is considered to be the major tool in pharmaceutical industry. Failures in
the quality of upcoming new chemical entities have been seen in the recent years due to …

Formulation and optimization of doxorubicin loaded polymeric nanoparticles using Box-Behnken design: ex-vivo stability and in-vitro activity

MV Shaikh, M Kala, M Nivsarkar - European Journal of Pharmaceutical …, 2017 - Elsevier
Biodegradable nanoparticles (NPs) have gained tremendous interest for targeting
chemotherapeutic drugs to the tumor environment. Inspite of several advances sufficient …

Poly ɛ-caprolactone nanoparticles loaded with Uncaria tomentosa extract: preparation, characterization, and optimization using the Box–Behnken design

AF Ribeiro, RL de Oliveira Rezende… - International journal …, 2013 - Taylor & Francis
Purpose The aim of this research was to develop and optimize a process for obtaining poly
ɛ-caprolactone (PCL) nanoparticles loaded with Uncaria tomentosa (UT) extract. Methods …

Application of rotatable central composite design in the preparation and optimization of poly(lactic-co-glycolic acid) nanoparticles for controlled delivery of paclitaxel

S Kollipara, G Bende, S Movva… - Drug Development and …, 2010 - Taylor & Francis
Context: Polymeric carrier systems of paclitaxel (PCT) offer advantages over only available
formulation Taxol® in terms of enhancing therapeutic efficacy and eliminating adverse …

Formulation, optimization, hemocompatibility and pharmacokinetic evaluation of PLGA nanoparticles containing paclitaxel

P Mittal, H Vardhan, G Ajmal, GV Bonde… - Drug development …, 2019 - Taylor & Francis
Abstract Objective: Paclitaxel (PTX)-loaded polymer (Poly (lactic-co-glycolic acid), PLGA)-
based nanoformulation was developed with the objective of formulating cremophor EL-free …

[PDF][PDF] Application of Plackett-Burman Factorial Design in The Development of Curcumin Loaded Eudragit E 100 Nanoparticles.

M Chidambaram, K Krishnasamy - Nano Biomedicine & Engineering, 2013 - nanobe.org
The present study was aimed to fabricate Curcumin loaded Eudragit E 100 polymeric
nanoparticles and to study the effect of various manufacturing parameters on the average …

Design expert as a statistical tool for optimization of 5-ASA-loaded biopolymer-based nanoparticles using Box Behnken factorial design

W Akram, N Garud - Future Journal of Pharmaceutical Sciences, 2021 - Springer
Background The overall objective was to prepare a highly accurate nanocarrier system of
mesalamine for the treatment of ulcerative colitis with increased therapeutic efficacy and …

Box–Behnken design of experiments of polycaprolactone nanoparticles loaded with irinotecan hydrochloride

BS Mahmoud, C McConville - Pharmaceutics, 2023 - mdpi.com
Background: The Box–Behnken design of experiments (BBD) is a statistical modelling
technique that allows the determination of the significant factors in developing nanoparticles …

[HTML][HTML] Optimization and in-vivo evaluation of isradipine nanoparticles using Box-Behnken design surface response methodology

V Venugopal, KJ Kumar, S Muralidharan… - OpenNano, 2016 - Elsevier
The isradipine is the potent anti hypertensive drug, which is matrix in polymeric nanoparticle
by using solvent evaporation method. In this work, 3-factor, 3-level Box-Behnken design was …